INVESTOR OVERVIEW

Recent Press Releases

Featured
Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG
Scinai Immunotherapeutics’ CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services
Scinai leadership to attend BIO-Europe Spring 2024
Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

Corporate Presentation

Corporate Governance

Code of Conduct >

Nominating and Governance Committee Charter >

Compensation Committee Charter >

Audit Committee Charter >

Board Diversity Matrix (PDF) >

Recent Quarterly & Annual Filings

Q3 2023 Quarterly Financial Results

Q2 2023 Quarterly Financial Results

FY 2022 Financial Statements and Annual Report

Investor Relations Contact

Joshua Phillipson | t: +972-8-930-2529 | e: ir@scinai.com